Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031
Vincent J. Picozzi(Virginia Mason Medical Center), Ross A. Abrams(Rush University Medical Center), Paul A. Decker, William Traverso(Virginia Mason Medical Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Edward Greeno(University of Minnesota), Robert C.G. Martin(Norton Healthcare), Lalan S. Wilfong(Texas Oncology), Mace L. Rothenberg(Vanderbilt-Ingram Cancer Center), Mitchell C. Posner(University of Chicago), Peter W. T. Pisters(The University of Texas MD Anderson Cancer Center)
Cited by 104Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis